Fibrin Clot Inhibitor Medication and Efficacy of Bacillus Calmette-Guerin for Bladder Urothelial Cancer Academic Article uri icon

Overview

MeSH Major

  • Adjuvants, Immunologic
  • Anticoagulants
  • Aspirin
  • BCG Vaccine
  • Carcinoma, Transitional Cell
  • Fibrinolytic Agents
  • Platelet Aggregation Inhibitors
  • Ticlopidine
  • Urinary Bladder Neoplasms
  • Warfarin

abstract

  • These data suggest that the risks of recurrence and progression to surgery after bacillus Calmette-Guerin are higher in patients on warfarin, while the risk of progression is lower in patients on aspirin. These findings may have important treatment implications in patients in whom bacillus Calmette-Guerin is contemplated.

publication date

  • October 2009

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1016/j.juro.2009.06.026

PubMed ID

  • 19683284

Additional Document Info

start page

  • 1306

end page

  • 12

volume

  • 182

number

  • 4 SUPPL.